| |
|
|
| Name: |
BAKER BROS ADVISORS LLC |
| City: |
NEW YORK |
| State: |
NY |
| Zip: |
10021 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
42 |
|
View All Holdings |
Currently
Viewing:
Unchanged Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
ACAD |
Acadia Pharmaceuticals Inc |
3 |
- |
$17.07 |
$1,342,091,000 |
42,864,612 |
15.51% |
448,792,000 |
0 |
26.664 |
Biotechnology |
|
|
IMCR |
Immunocore Holdings Adr |
7 |
- |
$54.74 |
$172,216,000 |
2,520,731 |
1.99% |
41,390,000 |
0 |
5.756 |
N/A |
|
|
TRDA |
Entrada Therapeutics, Inc. |
13 |
- |
$0.00 |
$73,425,000 |
4,865,819 |
0.85% |
-3,455,000 |
0 |
15.59 |
N/A |
|
|
ARGX |
Argenx Se |
18 |
- |
$358.41 |
$57,527,000 |
151,215 |
0.66% |
-16,815,000 |
0 |
0.322 |
N/A |
|
|
AKRO |
Akero Therapeutics, Inc. |
20 |
- |
$0.00 |
$55,302,000 |
2,368,378 |
0.64% |
-64,491,000 |
0 |
4.715 |
N/A |
|
|
KOD |
Kodiak Sciences Inc. |
21 |
- |
$3.47 |
$52,624,000 |
17,310,490 |
0.61% |
21,465,000 |
0 |
38.64 |
N/A |
|
|
KNSA |
Kiniksa Pharmaceuticals, Ltd. |
22 |
- |
$16.88 |
$49,280,000 |
2,809,577 |
0.57% |
478,000 |
0 |
8.332 |
N/A |
|
|
PRLD |
Prelude Therapeutics Inc |
24 |
- |
$0.00 |
$43,229,000 |
10,123,824 |
0.5% |
11,946,000 |
0 |
23.167 |
N/A |
|
|
NRIX |
Nurix Therapeutics, Inc. |
26 |
- |
$0.00 |
$40,064,000 |
3,882,125 |
0.46% |
9,550,000 |
0 |
8.253 |
N/A |
|
|
IDYA |
Ideaya Biosciences, Inc. |
28 |
- |
$0.00 |
$37,790,000 |
1,062,123 |
0.44% |
9,134,000 |
0 |
2.208 |
N/A |
|
|
BMEA |
Biomea Fusion, Inc. |
33 |
- |
$11.16 |
$30,622,000 |
2,108,949 |
0.35% |
1,603,000 |
0 |
7.33 |
N/A |
|
|
GLUE |
Monte Rosa Therapeutics, Inc. |
34 |
- |
$0.00 |
$27,776,000 |
4,916,095 |
0.32% |
4,228,000 |
0 |
11.05 |
N/A |
|
|
KRYS |
Krystal Biotech Inc |
36 |
- |
$163.97 |
$21,082,000 |
169,934 |
0.24% |
1,370,000 |
0 |
0.682 |
N/A |
|
|
IMVT |
Immunovant Inc |
38 |
- |
$0.00 |
$17,906,000 |
425,009 |
0.21% |
1,590,000 |
0 |
0.488 |
N/A |
|
|
TCRX |
Tscan Therapeutics, Inc. |
39 |
- |
$0.00 |
$16,235,000 |
2,784,792 |
0.19% |
9,106,000 |
0 |
14.956 |
N/A |
|
|
DAWN |
Day One Biopharmaceuticals,... |
40 |
- |
$0.00 |
$14,600,000 |
1,000,000 |
0.17% |
2,330,000 |
0 |
1.615 |
N/A |
|
|
DBVT |
DBV Technologies SA |
41 |
- |
$0.66 |
$13,924,000 |
14,614,264 |
0.16% |
-5,951,000 |
0 |
13.329 |
N/A |
|
|
RLAY |
Relay Therapeutics, Inc. |
42 |
- |
$6.11 |
$12,773,000 |
1,160,117 |
0.15% |
3,016,000 |
0 |
0.857 |
N/A |
|
|
SBTX |
Silverback Therapeutics, Inc. |
43 |
- |
$0.00 |
$10,995,000 |
2,006,451 |
0.13% |
3,411,000 |
0 |
1.159 |
N/A |
|
|
TSVT |
2seventy Bio, Inc. |
45 |
- |
$0.00 |
$10,664,000 |
2,497,526 |
0.12% |
874,000 |
0 |
4.807 |
N/A |
|
|
INSM |
Insmed Inc |
46 |
- |
$24.80 |
$10,630,000 |
343,000 |
0.12% |
1,969,000 |
0 |
0.226 |
Biotechnology |
|
|
PRME |
Prime Medicine, Inc. |
48 |
- |
$4.59 |
$9,112,000 |
1,028,466 |
0.11% |
-700,000 |
0 |
1.058 |
N/A |
|
|
ADAP |
Adaptimmune Therapeutics PLC |
50 |
- |
$0.90 |
$8,699,000 |
10,969,282 |
0.1% |
143,000 |
0 |
7.093 |
N/A |
|
|
SANA |
Sana Biotechnology, Inc. |
51 |
- |
$0.00 |
$8,160,000 |
2,000,000 |
0.09% |
420,000 |
0 |
1.067 |
N/A |
|
|
CELC |
Celcuity Inc. |
53 |
- |
$16.39 |
$7,802,000 |
535,478 |
0.09% |
2,908,000 |
0 |
2.471 |
N/A |
|
|
ATHA |
Athira Pharma, Inc. |
54 |
- |
$0.00 |
$7,664,000 |
3,153,807 |
0.09% |
1,293,000 |
0 |
10.233 |
N/A |
|
|
TNGX |
Tango Therapeutics Ord Shs |
56 |
- |
$0.00 |
$7,425,000 |
750,000 |
0.09% |
-1,020,000 |
0 |
0.857 |
N/A |
|
|
MIRM |
Mirum Pharmaceuticals, Inc. |
59 |
- |
$0.00 |
$5,623,000 |
190,476 |
0.06% |
-396,000 |
0 |
0.517 |
N/A |
|
|
LPTX |
Leap Therapeutics, Inc. |
61 |
- |
$2.96 |
$4,859,000 |
1,172,175 |
0.06% |
3,241,000 |
0 |
1.965 |
N/A |
|
|
DSGN |
Design Therapeutics, Inc. |
62 |
- |
$0.00 |
$3,975,000 |
1,500,000 |
0.05% |
435,000 |
0 |
2.697 |
N/A |
|
|
TLIS |
Talis Biomedical Corp |
63 |
- |
$0.00 |
$3,787,000 |
508,323 |
0.04% |
854,000 |
0 |
2.165 |
N/A |
|
|
ISR |
IsoRay, Inc. |
64 |
- |
$1.47 |
$3,071,000 |
7,639,703 |
0.04% |
980,000 |
0 |
13.886 |
Medical Instruments &... |
|
|
PCVX |
Vaxcyte, Inc. |
65 |
- |
$0.00 |
$3,070,000 |
48,885 |
0.04% |
578,000 |
0 |
0.045 |
N/A |
|
|
MRSN |
Mersana Therapeutics, Inc. |
68 |
- |
$3.34 |
$2,520,000 |
1,086,115 |
0.03% |
1,141,000 |
0 |
0.969 |
N/A |
|
|
CMPX |
Compass Therapeutics Ord Shs |
69 |
- |
$0.00 |
$2,430,000 |
1,557,630 |
0.03% |
-639,000 |
0 |
1.589 |
N/A |
|
|
KALA |
Kala Pharmaceuticals, Inc. |
71 |
- |
$6.81 |
$1,866,000 |
266,613 |
0.02% |
-507,000 |
0 |
17.563 |
N/A |
|
|
ALGS |
Aligos Therapeutics, Inc. |
72 |
- |
$0.00 |
$1,379,000 |
2,076,400 |
0.02% |
-172,000 |
0 |
5.927 |
N/A |
|
|
NVTA |
Invitae Corp |
73 |
- |
$0.00 |
$1,106,000 |
1,764,546 |
0.01% |
38,000 |
0 |
0.779 |
N/A |
|
|
PMVP |
Pmv Pharmaceuticals, Inc. |
75 |
- |
$0.00 |
$998,000 |
322,024 |
0.01% |
-979,000 |
0 |
0.592 |
N/A |
|
|
TARA |
Protara Therapeutics, Inc |
77 |
- |
$2.75 |
$374,000 |
199,671 |
0% |
41,000 |
0 |
1.9 |
N/A |
|
|
FHTX |
Foghorn Therapeutics Inc. |
79 |
- |
$0.00 |
$290,000 |
45,027 |
0% |
65,000 |
0 |
0.122 |
N/A |
|
|
SRZNW |
Surrozen Equity Warrant Exp... |
82 |
- |
$0.00 |
$16,000 |
833,333 |
0% |
-18,000 |
0 |
9.259 |
N/A |
|
